Clinical Trials Logo

Overactive Bladder clinical trials

View clinical trials related to Overactive Bladder.

Filter by:

NCT ID: NCT05798403 Recruiting - Overactive Bladder Clinical Trials

Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive Bladder

Start date: July 7, 2023
Phase: N/A
Study type: Interventional

Through a scientific and standardized multicenter, blinding, double-dummy, randomized controlled, noninferiority clinical trial study method, the investigators evaluated electroacupuncture as a safe and effective non-pharmacological treatment for OAB in women by comparison with Solifenacin Succinate.

NCT ID: NCT05783219 Completed - Overactive Bladder Clinical Trials

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

Start date: May 1, 2023
Phase: Phase 2
Study type: Interventional

The study will be a double-blind randomized control trial comparing 4% lidocaine patch placed over the sacrum 3 minutes prior to a percutaneous nerve evaluation (PNE) procedure to a placebo patch in patients already scheduled to undergo a medically indicated percutaneous nerve evaluation (PNE). VAS pain score, The volume of injectable lidocaine used, Patient Satisfaction Score, rate of successful PNE (defined as successful placement of wire in the S3 spinal foramen), and the amplitude of perineal stimulation on a Likert scale will be collected immediately after the procedure. Patients will follow up in 1 week - as is standard of care with the PNE procedure. Adverse events such as pain or change in sensation will be recorded. Number of voids and incontinence episodes per day after the PNE procedure will be recorded. Overall satisfaction score will be recorded at that time. Rate of progression to Sacral nerve stimulator implantation will be collected. The investigators hypothesize that patients in the lidocaine patch group will experience significantly less pain at the time of PNE as measured by a lower change in VAS pain score when compared with the control group.

NCT ID: NCT05772637 Recruiting - Overactive Bladder Clinical Trials

Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis

CUBS-MS
Start date: February 14, 2024
Phase: N/A
Study type: Interventional

The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.

NCT ID: NCT05719285 Completed - Overactive Bladder Clinical Trials

Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection

Start date: December 6, 2022
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to evaluate the outcomes of differing durations of antibiotic prophylaxis with bladder onabotulinumtoxinA injection in patients with refractory overactive bladder. The main question it aims to answer are: • Is the incidence of post-procedure UTI similar between single-dose and multi-day durations of peri-procedural antibiotics? Participants will be randomized to single-dose versus multi-day dose of antibiotic prophylaxis with bladder onabotulinumtoxinA injection. Researchers will compare incidence of UTI in each group to see if there is a significant difference.

NCT ID: NCT05709990 Completed - Overactive Bladder Clinical Trials

Efficacy and Safety of High Dose Vitamin D Supplementation for Overactive Bladder Dry in Children

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

This prospective, randomized, 3-arms, parallel-design, controlled clinical trial is conducted to determine whether high dose vitamin D supplementation (combined with standard urotherapy ) improves outcomes, compared with solifenacin (combined with standard urotherapy ) ,and standard urotherapy alone in children with OAB dry.

NCT ID: NCT05688644 Enrolling by invitation - Overactive Bladder Clinical Trials

Sacral Neuromodulation in Neurogenic Patients

Start date: December 19, 2021
Phase:
Study type: Observational

The goal of this observational study is to evaluate efficacy and safety of sacral neuromodulation in neurogenic patients compared to non-neurogenic (idiopathic) patients. [. The main question[s] it aims to answer are: - determine efficacy and safety of the therapy in neurogenic patients. - compare outcomes of the therapy to idiopathic patients. If there is a comparison group: Researchers will compare the outcomes of the therapy between the neurogenic and non-neurogenic subset of patients.

NCT ID: NCT05685433 Recruiting - Overactive Bladder Clinical Trials

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

RECIPE
Start date: January 26, 2023
Phase: N/A
Study type: Interventional

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

NCT ID: NCT05677841 Completed - Overactive Bladder Clinical Trials

Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive Bladder

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effects of spinal stabilization exercises focusing on the pelvic floor on urinary symptoms, spinal stability, pelvic floor muscle functions, quality of life and perception of recovery in women with overactive bladder.

NCT ID: NCT05672290 Not yet recruiting - Overactive Bladder Clinical Trials

Comparison of the Effects of External Electrical Stimulation Protocols in Women With Overactive Bladder

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The aim of our study is a comparison of the effects of external electrical stimulation protocols in women with overactive bladder (OAB).

NCT ID: NCT05672277 Not yet recruiting - Overactive Bladder Clinical Trials

Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

The aim of our study is a comparison of the effects of transcutaneous electrical nerve stimulation (TENS) protocols in women with overactive bladder (OAB).